We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novartis Hit With Gleevec Sham Litigation Class Action

Law360, New York (June 23, 2015, 5:29 PM EDT) -- ​Novartis Pharmaceuticals Corp. conspired to improperly withhold generic versions of Gleevec — a blockbuster leukemia medication — from the consumer market, two employee welfare funds alleged in a proposed class action...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.